Immunotech Biopharm Ltd (HKG:6978)
Hong Kong
· Delayed Price · Currency is HKD 2.950
-0.050 (-1.67%)
Jun 24, 2025, 3:53 PM HKT
Immunotech Biopharm Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| Cash & Equivalents | 46.96 | 52.16 | 58.45 | 353.34 | 845.39 | Upgrade
|
| Trading Asset Securities | 10.54 | 124.81 | 21.01 | - | - | Upgrade
|
| Cash & Short-Term Investments | 57.49 | 176.97 | 79.46 | 353.34 | 845.39 | Upgrade
|
| Cash Growth | -67.51% | 122.72% | -77.51% | -58.20% | 199.52% | Upgrade
|
| Other Receivables | 0.1 | - | - | - | - | Upgrade
|
| Receivables | 0.1 | - | - | - | - | Upgrade
|
| Inventory | 5.54 | 4.92 | 7.21 | 10.87 | 3.98 | Upgrade
|
| Other Current Assets | 24.36 | 32 | 31.44 | 47.99 | 34.36 | Upgrade
|
| Total Current Assets | 87.49 | 213.89 | 118.11 | 412.2 | 883.72 | Upgrade
|
| Property, Plant & Equipment | 451.6 | 500.76 | 527.25 | 426.59 | 154.49 | Upgrade
|
| Long-Term Investments | - | 46.36 | 140.18 | 163.18 | 131.97 | Upgrade
|
| Other Intangible Assets | 19.55 | 41.88 | 42.49 | 14.25 | 7.37 | Upgrade
|
| Long-Term Deferred Charges | 0.21 | 0.46 | 0.72 | 0.98 | 1.23 | Upgrade
|
| Other Long-Term Assets | 5.18 | 42.92 | 50.69 | 80.5 | 31.44 | Upgrade
|
| Total Assets | 564.04 | 846.28 | 879.44 | 1,098 | 1,210 | Upgrade
|
| Accounts Payable | 33.61 | 46.76 | 37.39 | 32.15 | 5.84 | Upgrade
|
| Accrued Expenses | 21 | 21.65 | 27.17 | 22.24 | 5.76 | Upgrade
|
| Current Portion of Long-Term Debt | 268.1 | 326.84 | - | - | - | Upgrade
|
| Current Portion of Leases | 27.45 | 24.68 | 26.06 | 20.21 | 7.2 | Upgrade
|
| Current Income Taxes Payable | 0.96 | - | - | - | - | Upgrade
|
| Current Unearned Revenue | 1.78 | 1.85 | 4.36 | 5.19 | 4.25 | Upgrade
|
| Other Current Liabilities | 77.31 | 108.5 | 113.49 | 100.31 | 8.57 | Upgrade
|
| Total Current Liabilities | 430.21 | 530.28 | 208.47 | 180.1 | 31.62 | Upgrade
|
| Long-Term Debt | - | - | 1 | - | - | Upgrade
|
| Long-Term Leases | 89.02 | 105.66 | 122.75 | 90.85 | 43.86 | Upgrade
|
| Long-Term Unearned Revenue | 61.27 | 39.46 | 40.84 | 3.56 | 5.91 | Upgrade
|
| Total Liabilities | 580.5 | 675.39 | 373.07 | 274.51 | 81.38 | Upgrade
|
| Common Stock | 3.58 | 3.58 | 3.58 | 3.58 | 3.58 | Upgrade
|
| Additional Paid-In Capital | 1,402 | 1,402 | 1,402 | 1,402 | 1,402 | Upgrade
|
| Retained Earnings | -1,805 | -1,618 | -1,283 | -965.22 | -610.99 | Upgrade
|
| Comprehensive Income & Other | 385.69 | 385.69 | 385.69 | 381.4 | 332.46 | Upgrade
|
| Total Common Equity | -13.3 | 173.62 | 508.44 | 822.26 | 1,128 | Upgrade
|
| Minority Interest | -3.16 | -2.73 | -2.07 | 0.92 | 1.31 | Upgrade
|
| Shareholders' Equity | -16.45 | 170.89 | 506.37 | 823.18 | 1,129 | Upgrade
|
| Total Liabilities & Equity | 564.04 | 846.28 | 879.44 | 1,098 | 1,210 | Upgrade
|
| Total Debt | 384.56 | 457.17 | 149.81 | 111.05 | 51.06 | Upgrade
|
| Net Cash (Debt) | -327.07 | -280.2 | -70.35 | 242.29 | 794.33 | Upgrade
|
| Net Cash Growth | - | - | - | -69.50% | 226.55% | Upgrade
|
| Net Cash Per Share | -0.64 | -0.54 | -0.14 | 0.47 | 1.79 | Upgrade
|
| Filing Date Shares Outstanding | 514.58 | 514.58 | 514.58 | 514.58 | 514.58 | Upgrade
|
| Total Common Shares Outstanding | 514.58 | 514.58 | 514.58 | 514.58 | 514.58 | Upgrade
|
| Working Capital | -342.71 | -316.38 | -90.36 | 232.1 | 852.11 | Upgrade
|
| Book Value Per Share | -0.03 | 0.34 | 0.99 | 1.60 | 2.19 | Upgrade
|
| Tangible Book Value | -32.85 | 131.73 | 465.95 | 808.01 | 1,120 | Upgrade
|
| Tangible Book Value Per Share | -0.06 | 0.26 | 0.91 | 1.57 | 2.18 | Upgrade
|
| Land | 83.92 | 83.92 | 83.92 | 63.05 | 50.15 | Upgrade
|
| Machinery | 153.36 | 149.53 | 86.1 | 76.5 | 41.34 | Upgrade
|
| Construction In Progress | 113.42 | 107.65 | 208.53 | 151.85 | 2.5 | Upgrade
|
| Leasehold Improvements | 121.83 | 121.83 | 56.69 | 56.25 | 28.99 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.